Last 12 months
Inside the activity.
0 purchase rows · 204 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 17 |
| Dec 2025 | 0 | 26 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 32 |
| Jul 2026 | 0 | 64 |
| Aug 2026 | 0 | 27 |
| Sep 2026 | 0 | 20 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2020 Filed Jun 2, 2020 20:11 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 431 | $165.12 | $71,168.10 |
DisclosureSEC source: 0001651308-20-000061 · wf-form4_159112868999563.xml · nonDerivative · entry 5 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.84 to $165.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 20:11 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 569 | $163.97 | $93,299.61 |
DisclosureSEC source: 0001651308-20-000061 · wf-form4_159112868999563.xml · nonDerivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.80 to $164.78, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 20:11 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 500 | $162.63 | $81,315.80 |
DisclosureSEC source: 0001651308-20-000061 · wf-form4_159112868999563.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.39 to $162.96, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 20:11 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 1,500 | $29.49 | $44,235.00 |
DisclosureSEC source: 0001651308-20-000061 · wf-form4_159112868999563.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:08 UTC |
Glazer Donald W.Director
|
SaleAmerican Depositary Shares | 10,000 | $169.84 | $1,698,400.00 |
DisclosureSEC source: 0001651308-20-000058 · wf-form4_159009168711042.xml · nonDerivative · entry 2 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.53 to $170.08, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:08 UTC |
Glazer Donald W.Director
|
GiftOrdinary Shares | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-20-000058 · wf-form4_159009168711042.xml · nonDerivative · entry 1 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,497,678 F1 · shares: Bona fide gifts of shares which are exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:48 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 474 | $141.00 | $66,834.00 |
DisclosureSEC source: 0001651308-20-000046 · wf-form4_158871168978852.xml · nonDerivative · entry 9 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/4th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:48 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 2,859 | $140.96 | $403,004.64 |
DisclosureSEC source: 0001651308-20-000046 · wf-form4_158871168978852.xml · nonDerivative · entry 8 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/4th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:48 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 302 | $143.17 | $43,237.13 |
DisclosureSEC source: 0001651308-20-000046 · wf-form4_158871168978852.xml · nonDerivative · entry 7 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/4th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.00 to $143.56, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:48 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,000 | $142.46 | $142,461.60 |
DisclosureSEC source: 0001651308-20-000046 · wf-form4_158871168978852.xml · nonDerivative · entry 6 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,635 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/4th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.00 to $142.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:46 UTC |
Wu XiaobinPresident & GM China
|
SaleAmerican Depositary Shares | 245 | $141.00 | $34,545.00 |
DisclosureSEC source: 0001651308-20-000045 · wf-form4_158871159383308.xml · nonDerivative · entry 7 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F4 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:46 UTC |
Wu XiaobinPresident & GM China
|
SaleAmerican Depositary Shares | 300 | $143.17 | $42,951.99 |
DisclosureSEC source: 0001651308-20-000045 · wf-form4_158871159383308.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F4 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.00 to $143.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:46 UTC |
Wu XiaobinPresident & GM China
|
SaleAmerican Depositary Shares | 1,224 | $142.54 | $174,469.20 |
DisclosureSEC source: 0001651308-20-000045 · wf-form4_158871159383308.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F4 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.00 to $142.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:46 UTC |
Wu XiaobinPresident & GM China
|
SaleAmerican Depositary Shares | 5,255 | $140.96 | $740,744.80 |
DisclosureSEC source: 0001651308-20-000045 · wf-form4_158871159383308.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,769 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F4 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 20:04 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001651308-20-000044 · wf-form4_158827705041334.xml · derivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,075 Underlying: Ordinary Shares · 19,500 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 20:04 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 1,500 | $162.30 | $243,450.00 |
DisclosureSEC source: 0001651308-20-000044 · wf-form4_158827705041334.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2019. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 20:04 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 1,500 | $29.49 | $44,235.00 |
DisclosureSEC source: 0001651308-20-000044 · wf-form4_158827705041334.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 20:04 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001651308-20-000043 · wf-form4_158715384034366.xml · derivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,575 Underlying: Ordinary Shares · 19,500 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 20:04 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 1,500 | $160.00 | $240,000.00 |
DisclosureSEC source: 0001651308-20-000043 · wf-form4_158715384034366.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2019. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 20:04 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 1,500 | $29.49 | $44,235.00 |
DisclosureSEC source: 0001651308-20-000043 · wf-form4_158715384034366.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| March 04, 2020 Filed Mar 7, 2020 01:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 201 | $158.63 | $31,884.35 |
DisclosureSEC source: 0001651308-20-000022 · wf-form4_158354463930038.xml · nonDerivative · entry 7 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · security: Each American Depositary Share represents 13 Ordinary Shares. F5 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2019. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.59 to $159.34, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| March 04, 2020 Filed Mar 7, 2020 01:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 1,768 | $157.51 | $278,475.74 |
DisclosureSEC source: 0001651308-20-000022 · wf-form4_158354463930038.xml · nonDerivative · entry 6 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201 F4 · security: Each American Depositary Share represents 13 Ordinary Shares. F5 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2019. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.24 to $157.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| March 04, 2020 Filed Mar 7, 2020 01:30 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 3,031 | $156.82 | $475,321.12 |
DisclosureSEC source: 0001651308-20-000022 · wf-form4_158354463930038.xml · nonDerivative · entry 5 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,969 F4 · security: Each American Depositary Share represents 13 Ordinary Shares. F5 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.18 to $157.17, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| March 03, 2020 Filed Mar 7, 2020 01:29 UTC |
HOOPER ANTHONY CDirector
|
GrantShare Option (Right to Buy) · Derivative | 21,970 | $0.00 Strike: $12.22 | $0.00 |
DisclosureSEC source: 0001651308-20-000021 · wf-form4_158354457657923.xml · derivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,970 Underlying: Ordinary Shares · 21,970 shares Expires 2030-03-02 F1 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F1 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F2 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:13 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001651308-20-000015 · wf-form4_158223316961612.xml · derivative · entry 5 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,075 Underlying: Ordinary Shares · 19,500 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:13 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 321 | $171.14 | $54,934.78 |
DisclosureSEC source: 0001651308-20-000015 · wf-form4_158223316961612.xml · nonDerivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.67 to $171.66, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:13 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 1,179 | $170.01 | $200,445.21 |
DisclosureSEC source: 0001651308-20-000015 · wf-form4_158223316961612.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.56 to $170.39, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:13 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 1,500 | $29.49 | $44,235.00 |
DisclosureSEC source: 0001651308-20-000015 · wf-form4_158223316961612.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 23:59 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001651308-20-000009 · wf-form4_157973753974803.xml · derivative · entry 6 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,575 Underlying: Ordinary Shares · 19,500 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 23:59 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 87 | $172.34 | $14,993.58 |
DisclosureSEC source: 0001651308-20-000009 · wf-form4_157973753974803.xml · nonDerivative · entry 5 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 23:59 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 600 | $171.27 | $102,762.00 |
DisclosureSEC source: 0001651308-20-000009 · wf-form4_157973753974803.xml · nonDerivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.79 to $171.78, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 23:59 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 813 | $170.09 | $138,286.91 |
DisclosureSEC source: 0001651308-20-000009 · wf-form4_157973753974803.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.75 to $170.57, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 23:59 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 1,500 | $29.49 | $44,235.00 |
DisclosureSEC source: 0001651308-20-000009 · wf-form4_157973753974803.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 21:10 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,958 | $165.61 | $324,262.81 |
DisclosureSEC source: 0001651308-19-000136 · wf-form4_157678981368580.xml · nonDerivative · entry 12 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · security: Each American Depositary Share represents 13 Ordinary Shares F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2019. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.35 to 165.86, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 21:10 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 200 | $163.20 | $32,640.00 |
DisclosureSEC source: 0001651308-19-000136 · wf-form4_157678981368580.xml · nonDerivative · entry 11 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,958 F5 · security: Each American Depositary Share represents 13 Ordinary Shares F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2019. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 21:10 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 2,400 | $162.42 | $389,796.48 |
DisclosureSEC source: 0001651308-19-000136 · wf-form4_157678981368580.xml · nonDerivative · entry 10 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,158 F5 · security: Each American Depositary Share represents 13 Ordinary Shares F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2019. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.095 to $162.85, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 21:10 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 18,215 | $161.49 | $2,941,527.60 |
DisclosureSEC source: 0001651308-19-000136 · wf-form4_157678981368580.xml · nonDerivative · entry 9 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,558 F5 · security: Each American Depositary Share represents 13 Ordinary Shares F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2019. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.06 to $162.055, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 21:10 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 16,965 | $160.60 | $2,724,572.21 |
DisclosureSEC source: 0001651308-19-000136 · wf-form4_157678981368580.xml · nonDerivative · entry 8 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,773 F5 · security: Each American Depositary Share represents 13 Ordinary Shares F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2019. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.06 to $161.05, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 21:10 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 15,466 | $159.59 | $2,468,195.74 |
DisclosureSEC source: 0001651308-19-000136 · wf-form4_157678981368580.xml · nonDerivative · entry 7 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,738 F5 · security: Each American Depositary Share represents 13 Ordinary Shares F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2019. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.06 to $160.05, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 21:10 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 7,055 | $158.63 | $1,119,105.02 |
DisclosureSEC source: 0001651308-19-000136 · wf-form4_157678981368580.xml · nonDerivative · entry 6 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,204 F5 · security: Each American Depositary Share represents 13 Ordinary Shares F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2019. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.06 to $159.02, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:57 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001651308-19-000135 · wf-form4_157671345970404.xml · derivative · entry 10 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 578,075 Underlying: Ordinary Shares · 19,500 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:57 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 100 | $173.59 | $17,359.00 |
DisclosureSEC source: 0001651308-19-000135 · wf-form4_157671345970404.xml · nonDerivative · entry 9 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:57 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 100 | $172.13 | $17,213.00 |
DisclosureSEC source: 0001651308-19-000135 · wf-form4_157671345970404.xml · nonDerivative · entry 8 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:57 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 200 | $170.73 | $34,145.00 |
DisclosureSEC source: 0001651308-19-000135 · wf-form4_157671345970404.xml · nonDerivative · entry 7 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.31 to $171.14, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:57 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 100 | $168.90 | $16,890.00 |
DisclosureSEC source: 0001651308-19-000135 · wf-form4_157671345970404.xml · nonDerivative · entry 6 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:57 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 100 | $165.55 | $16,555.00 |
DisclosureSEC source: 0001651308-19-000135 · wf-form4_157671345970404.xml · nonDerivative · entry 5 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:57 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 800 | $161.93 | $129,541.36 |
DisclosureSEC source: 0001651308-19-000135 · wf-form4_157671345970404.xml · nonDerivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.77 to $162.52, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:57 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 100 | $160.07 | $16,007.00 |
DisclosureSEC source: 0001651308-19-000135 · wf-form4_157671345970404.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:57 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 1,500 | $29.49 | $44,235.00 |
DisclosureSEC source: 0001651308-19-000135 · wf-form4_157671345970404.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 21:00 UTC |
Glazer Donald W.Director
|
GiftOrdinary Shares | 81,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-19-000120 · wf-form4_157445640632379.xml · nonDerivative · entry 1 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,630,366 F1 · shares: Bona fide gifts of shares which are exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.